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Summary: Lymphoedema (so! tissue swelling resulting from obstruction of 
the lymphatic drainage system) is a chronic illness that has immense physical and 
psychological impact on a patient’s life. 
Relevance: Management of this illness, while conservative, can be life chang-
ing when approached by a co-ordinated multidisciplinary team. (1,2) In the UK, 
specialist lymphoedema services are o!en run from hospices. 
Take-home messages: Although some patients with lymphoedema will 
require minimal support, it is vital that patients and healthcare professionals are 
vigilant for rare but serious complications.
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Primary lymphoedema is usually occurs as a result of congenital 
physiological abnormalities, one example being Milroy’s disease. 
Secondary lymphoedema may be iatrogenic (following surgical 
removal of lymph nodes as part of cancer treatment, most common 
in developed countries) or post infectious (a key cause in developing 
countries, particularly "lariasis in South East Asia). (3,4) Previ-
ously known as elephantitis, "lariasis is a parasitic infection of the 
lymphatic vessels by nematodes (roundworms) belonging to the 
Filariodidea family. (5) Even though this illness poses a huge global 
challenge, there are very few lymphoedema specialists outside of 
Europe. (6)
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Lymphoedema is usually diagnosed clinically. Patients complain of 
uncomfortable swelling and skin atrophy in an extremity (includ-
ing the scrotum, head, and neck) following infection or surgery. (3) 
Common pitfalls in diagnosis lie in the di#erential diagnoses such 
as cellulitis and peripheral vascular disease. In cases of uncertainty, 
it is important to note that specialist diagnostic tests are available, 
including tissue tonometry (non-invasive) and lymphoscintigraphy 
or MR lymphangiography (invasive). (3)
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Most lymphoedema is treated conservatively, guided by symptom 
burden, and led by a lymphoedema specialist nurse. Specialist lym-
phoedema services, (1) along with psychology and physiotherapy 
input have proven to have better patient outcomes. (7) In one inten-
sive specialist intervention programme over half of their participants 
achieved a 50% reduction in lymphoedema. (2) Patient education 
plays a vital role. Patients bene"t from lymphoedema specialists 
ensuring they understand the condition, including important and 
serious risks. (8) 
Non-surgically, the aim of therapy is to reduce the volume of 
lymph $uid in the tissue, thereby reducing pain, weight, and the 
likelihood of local infection. (4) This can be achieved by a decon-
gestive lymphatic therapy (DLT) which is a combination of manual 
lymph drainage and compression bandaging. DLT in combination 
with adjuvant skin care and light exercise can take months of in-
tensive treatment to take e#ect. Newer techniques such as laser and 
pneumatic decompression are also available. (4)
Pharmacologically, diuretics are not recommended outside of co-
morbid renal/cardiac failure. (9) In general antibiotics should only 
be used during episodes of cellulitis or for long term prophylaxis in 
recurrent cellulitis e.g. more than twice in 12 months. (10) In the 
context of post-infective lymphoedema, the World Health Organi-
sation recommends annual preventative chemotherapy in endemic 
areas to end the cycle of nematode infection. (5) Liposuction, tissue 
excision and lymphatic bypass are all potential surgical options. 
(11) However, at present NICE has only deemed liposuction as 
adequately safe and e#ective. (12)
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In the chronic care of patients with lymphoedema, reducing risk 
of complications is a huge component. The theoretical risk of 
infection should be avoided. Experts advise diligent skincare and 
avoiding invasive procedures (venepuncture, cannulation) on a lym-
phoedematous limb where possible (10, 13, 14). Sudden worsening 
of lymphoedema should be actively investigated. While a concomi-
tant oedema (for example, cardiogenic) may be a cause, venous 
thromboembolism, cellulitis, or recurrent carcinoma could also be 
responsible (3, 14). A rare and fatal condition which can occur in 
chronic lymphoedema is lymphangiosarcoma, a so! tissue neopla-
sia, known as Stewart Treves syndrome, which requires specialist 
input from dermatology and Lymphoedema services. (15) Stewart 
Treves syndrome has a poor prognosis and should be considered 
in patients with long term lymphoedema who present with skin 
changes such as nodules or non-healing ulcers. (15)
)$+&	$)
1. Tissue swelling could be lymphoedema in any patient. Con-
sider congenital and infective causes if there is no history of node 
removal, as globally, lymphoedema is not always a cancer-related 
diagnosis.
2. Involvement of specialist lymphoedema services has signi"cantly 
better outcomes and should be an early priority in suspected cases.  
3. Patients with lymphoedema are at high risk of local infection. 
Bear this in mind when carrying out any invasive procedure, right 
down to venepuncture. 
4. In a patient with pre-existing lymphoedema, sudden worsening 
should be investigated fully: consider venous thromboembolism, 
cellulitis, recurrent carcinoma, or oedema of another cause. A rare 
but fatal complication is lymphangiosarcoma. 
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